In this podcast, Laurence Slama, MD, PhD, discusses the logistics of allowing patients to seek a nurse in their community to administer their long-acting injectable ART after receiving the first few doses in a clinical setting.
In this episode, Laurence Slama, MD, PhD, describes some of the ways that her clinic is attempting to make IM injections of long-acting antiretroviral therapy more sustainable long term. She explains the logistics of how she has allowed for patients to receive their long-acting cabotegravir and rilpivirine doses through community nurses after receiving the first 3 doses in a clinical setting. She also discusses some of the benefits and challenges of this kind of flexible system for patients and healthcare professionals.
Laurence Slama
Doctor
Department of Infectious Diseases
Hôtel Dieu, APHP
Paris, France
See the full program at:
https://bit.ly/3CsSvdX